Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay

Japanese Journal of Infectious Diseases

Volumn 61, Issue 5, 2008, Pages 415-418

  Harada, Nobuyuki ^a   Higuchi, Kazue ^a   Mori, Toru ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON; ISONIAZID;

ADULT; AGED; ARTICLE; ASSAY; BACTERIUM CULTURE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LUNG TUBERCULOSIS; MALE; MEDICAL EXAMINATION; MENTAL HOSPITAL; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING; THORAX RADIOGRAPHY; TUBERCULIN TEST; ANALYTICAL EQUIPMENT; BLOOD; CROSS INFECTION; FEMALE; HOSPITAL PATIENT; HOSPITAL PERSONNEL; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PERSONNEL, HOSPITAL; REAGENT KITS, DIAGNOSTIC; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 54449096614     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aoki, M. (1991): Surveillance Of tuberculosis in low prevalence countries where tuberculosis is in decline. BulL Int. Union Tuberc. Lung Dis. 66, 201-202.
2. Ministry of Health, Labour and Welfare (2007): Statistics of tuberculosis outbreaks.
3. Aoki, M. (1999): Nosocomial transmission of tuberculosis. 2nd ed. JATA BOOKS, Tokyo (in Japanese).
4. Huebner, R.E., Schein, M.F. and Bass, J.B., Jr. (1993): The tuberculin skin test. Clin, Infect. Dis., 17, 968-975.
5. Andersen, P., Munk, M.E., Pollock, J.M., et al. (2000): Specific immune-based diagnosis of tuberculosis. Lancet, 356, 1099-1104.
6. Andersen, P., Andersen, A.B., Sorensen, A.L., et al. (1995): Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol., 154, 3359-3372.
7. Sorensen, A.L., Nagai, S., Houen, G., et al. (1995): Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun., 63, 1710-1717.
8. Skjøt, R.L., Oettinger, T., Rosenkrands, I., et al. (2000): Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect. Immun., 68, 214-220.
9. Mori, T., Sakatani, M., Yamagishi, F., et al. (2004): Specific detection of tuberculosis infection with an interferon-gamma based assay using new antigens. Am. J. Respir. Crit. Care Med., 170, 59-64.
10. Harada, N., Mori, T., Shishido, S., et al. (2004): Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON®TB-2G, in an outbreak of tuberculosis. Kekkaku, 79, 637-643 (in Japanese).
11. Brock, I., Weldingh, K., Lilleback, T., et al. (2004): Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med., 170, 65-69.
12. Funayama, K., Tsujimoto, A., Mori, M., et al. (2005): Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university. Kekkaku, 80, 527-534 (in Japanese).
13. Kang, Y.A., Lee, H.W., Yoon, H.I., et al. (2005): Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA, 293,2756-2761.
14. Harada, N., Nakajima, Y., Higuchi, K., et al. (2006): Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect. Control Hosp. Epidemiol., 27, 442-448.
15. Diel, R., Nienhaus, A., Lange, C., et al. (2006): Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir. Res., 7, 77.
16. Connell, T.G., Rangaka, M.X., Curtis, N., et al. (2006): QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev. Mol. Diagn., 6,663-677.
17. Higuchi, K., Harada, N., Mori, T., et al. (2007): Use of QuantiFERON®-TB Gold to investigate tuberculosis contacts in a high school. Respirology, 12,88-92.
18. Centers for Disease Control and Prevention (1994): Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare facilities. Morbid. Mortal. Wkly. Rep., 43 (RR-13),1-132.
19. Wiggins, J., Hearn, G. and Skinner, C. (1989): Recent experience in the control and management of tuberculosis in a mental handicap hospital. Respit. Med., 83, 315-319.
20. Lemaitre, N., Sougakoff, W., Coetmeur, D., et al. (1996): Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility. Tuber. Lung Dis., 77, 531-536.
21. Fukazawa, K., Aritake, S., Minemura, S., et al. (2000): A tuberculosis outbreak in a mental hospital. Jpn. J. Public Health, 47, 801-808 (in Japanese).
22. Diaz, R., Gomez, R.I., Garcia, N., et al. (2001): Molecular epidemiological study on transmission of tuberculosis in a hospital for mentally handicapped patients in Havana, Cuba. J. Hosp. Infect., 49, 30-36.
23. Ota, M. and Isshiki, M. (2004). An outbreak of tuberculosis in a longterm care unit of a mental hospital. Kekkaku, 79, 579-586 (in Japanese).
24. MacNeil, J., Lobato, M.N. and Moore, M. (2005): An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am. J. Public Health, 95, 1800-1805.
25. Centers for Disease Control and Prevention (2005): Tuberculosis transmission in a homeless shelter population-New York, 2000-2003. Morbid. Mortal. Wkly. Rep., 54, 149-152.
26. Mori, T. (2000): Recent trends in tuberculosis, Japan. Emerg. Infect. Dis., 6, 566-568.
27. Yamaguchi, J., Ooba, Y., Kaneda, M., et al. (2007).-Outbreak of pulmonary tuberculosis in which tuberculosis developed from QuantiFERON-TB second generation (QFT-2G) test negative persons. Kekkaku, 82, 629-634 (in Japanese).